Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study

References

• Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–71. doi: 10.1016/j.jhep.2018.09.014
   PubMed Web of Science ®Google Scholar
• Smith A, Baumgartner K, Bositis C. Cirrhosis: diagnosis and management. Am Fam Physician. 2019;100(12):759–70.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Morabito A, D’Amico M, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68(3):563–76. doi: 10.1016/j.jhep.2017.10.020
   PubMed Web of Science ®Google Scholar
• Ginès P, Krag A, Abraldes JG, et al. Liver cirrhosis. Lancet (London, England). 2021;398(10308):1359–76. doi: 10.1016/S0140-6736(21)01374-X
   PubMed Web of Science ®Google Scholar
• Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine. 2016;95(8):e2877. doi: 10.1097/MD.0000000000002877
   PubMed Web of Science ®Google Scholar
• Zipprich A, Garcia-Tsao G, Rogowski S, et al. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32(9):1407–14. doi: 10.1111/j.1478-3231.2012.02830.x
   PubMed Web of Science ®Google Scholar
• Romanelli RG, Stasi C. Recent advancements in diagnosis and therapy of liver cirrhosis. Curr Drug Targets. 2016;17(15):1804–17. doi: 10.2174/1389450117666160613101413
   PubMed Web of Science ®Google Scholar
• Qi X, Li Y, Wang R, et al. Liaoning Score for prediction of esophageal varices in cirrhotic patients who had never undergone endoscopy: a multicenter cross-sectional study in Liaoning Province, China. Adv Ther. 2019;36(8):2167–78. doi: 10.1007/s12325-019-00967-w
   PubMed Web of Science ®Google Scholar
• Li Q, Wu Y, Zhu Q, et al. External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study. Ann Transl Med. 2019;7(23):755. doi: 10.21037/atm.2019.11.78
   PubMed Web of Science ®Google Scholar
• Wang L, Guo X, Bai Z, et al. Impact of asymptomatic superior mesenteric vein thrombosis on the outcomes of patients with liver cirrhosis. Thromb Haemost. 2022;122(12):2019–29. doi: 10.1055/s-0042-1756648
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9. doi: 10.1002/bjs.1800600817
   PubMed Web of Science ®Google Scholar
• Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797–805.
   PubMed Web of Science ®Google Scholar
• Ibrahim M, Mostafa I, Devière J. New developments in managing variceal bleeding. Gastroenterology. 2018;154(7):1964–9. doi: 10.1053/j.gastro.2018.02.023
   PubMed Web of Science ®Google Scholar
• Kok B, Abraldes JG. Child-Pugh classification: time to abandon? Semin Liver Dis. 2019;39(1):96–103.
   PubMed Web of Science ®Google Scholar
• Tarlow BD, Kim WR, Mannalithara A, et al. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40. Hepatology. 2023;77(3):851–61. doi: 10.1002/hep.32770
   PubMed Web of Science ®Google Scholar
• Haryono H, Bestari MB, Girawan D, et al. Prediction of esophageal varices grading in cirrhotic patients using Liaoning, albumin-bilirubin and platelets-albumin-bilirubin score. Hepatol Int. 2021;15(Suppl 1):96–7.
   Google Scholar
• Deng Z, Qin S, Jiang H. Comparison between Liaoning scoring system and three other non‑invasive scoring systems in the prediction of high‑risk esophageal varices and hemorrhage or re‑hemorrhage in patients with liver cirrhosis (Article in Chinese). Chin J Dig Endosc. 2022;39(5):388–93.
   Google Scholar
• Shikdar S, Vashisht R, Bhattacharya PT. International normalized ratio (INR). StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2023.
   Google Scholar
• Arjal R, Trotter JF. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure. Clin Liver Dis. 2009;13(1):67–71. doi: 10.1016/j.cld.2008.09.009
   PubMed Web of Science ®Google Scholar
• Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol. 2002;36(4):494–500. doi: 10.1016/S0168-8278(01)00309-9
   PubMed Web of Science ®Google Scholar
• Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003;52(1):134–9. doi: 10.1136/gut.52.1.134
   PubMed Web of Science ®Google Scholar
• Qiao L, Tan W, Wang X, et al. Different effects of total bilirubin on 90-day mortality in hospitalized patients with cirrhosis and advanced fibrosis: a quantitative analysis. Front Med (Lausanne). 2021;8:704452. doi: 10.3389/fmed.2021.704452
   PubMed Web of Science ®Google Scholar
• López-Velázquez JA, Chávez-Tapia NC, Ponciano-Rodríguez G, et al. Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator. Ann Hepatol. 2013;13(1):98–104. doi: 10.1016/S1665-2681(19)30910-X
   PubMed Web of Science ®Google Scholar
• Xu X, Liu B, Lin S, et al. Terlipressin may decrease in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding and renal dysfunction: a retrospective multicenter observational study. Adv Ther. 2020;37(10):4396–413. doi: 10.1007/s12325-020-01466-z
   PubMed Web of Science ®Google Scholar
• Bai Z, Primignani M, Guo X, et al. Incidence and mortality of renal dysfunction in cirrhotic patients with acute gastrointestinal bleeding: a systematic review and meta-analysis. Exp Rev Gastroenterol Hepatol. 2019;13(12):1181–8. doi: 10.1080/17474124.2019.1694904
   PubMed Web of Science ®Google Scholar
• Desai AP, Knapp SM, Orman ES, et al. Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. J Hepatol. 2020;73(5):1092–9. doi: 10.1016/j.jhep.2020.04.043
   PubMed Web of Science ®Google Scholar
• Wen J, Chen X, Wei S, et al. Research progress and treatment status of liver cirrhosis with hypoproteinemia. Evid Based Complement Alternat Med. 2022;2022:2245491. doi: 10.1155/2022/2245491
   PubMed Web of Science ®Google Scholar
• Bai Z, Guo X, Tacke F, et al. Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization. Therap Adv Gastroenterol. 2019;12:1756284819881302. doi: 10.1177/1756284819881302
   Web of Science ®Google Scholar
• Mallik M, Singhai A, Khadanga S, et al. The significant morbidity and mortality indicators in patients of cirrhosis. Cureus. 2022;14(1):e21226. doi: 10.7759/cureus.21226
   PubMed Web of Science ®Google Scholar
• Ferrarese A, Frigo AC, Mion MM, et al. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection. Clin Chem Lab Med. 2021;59(4):775–82. doi: 10.1515/cclm-2020-1212
   PubMed Web of Science ®Google Scholar
• Barnard A, Moch A, Saab S. Relationship between telomere maintenance and liver disease. Gut Liver. 2019;13(1):11–5. doi: 10.5009/gnl18081
   PubMed Web of Science ®Google Scholar